AI assistant
AVANOS MEDICAL, INC. — Director's Dealing 2024
Mar 19, 2024
32765_dirs_2024-03-19_a609a921-56d9-418c-a86a-010542a5cdc7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVANOS MEDICAL, INC. (AVNS)
CIK: 0001606498
Period of Report: 2024-03-18
Reporting Person: Holbrook Kerr (SVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-18 | Common Stock | M | 2531 | — | Acquired | 89727 | Direct |
| 2024-03-18 | Common Stock | F | 756 | $19.09 | Disposed | 88971 | Direct |
| 2024-03-18 | Common Stock | F | 2840 | $19.09 | Disposed | 86131 | Direct |
Footnotes
F1: Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each PRSU is the economic eqiuvalent of one share of Common Stock.
F2: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 2,531 PRSUs which vested on March 18, 2024.
F3: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 9,516 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each TRSU is the economic equivalent of one share of Common Stock.